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Foot ulcers associated with Diabetes mellitus require 
immediate attention due to risk of amputation if left 
untreated. Herein we focus on the mitigating risk 
factors and physiopathology of the diabetic foot, 
recounting our own surgical approach and 
revascularization procedures. 
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I.  INTRODUCTION 
 
Diabetes mellitus (DM) is one of the most common 
chronic diseases and largest global health 
emergencies of the 21st century. Prevalence of types 
1 and 2 diabetes is on the rise and in 2015, 415 million 
adults worldwide were estimated to have had DM, 
including 193 million undiagnosed people and 318 
million adults affected with impaired glucose 
tolerance; a condition that indicates high risk for 
developing the disease in the future. It is expected that 
if this number is not reduced, by 2040 up to 642 
million people will be diagnosed with diabetes.1 
Chronic diseases such as DM are causing increasing 
numbers of deaths worldwide. In 2015 of 56,4 million 
deaths across the globe diabetes, which represents the 
sixth leading cause of global deaths in 2015, killed 1.6 
million people, up from fewer than 1 million in 2000.2 
Microvascular (neuropathy, retinopathy, 
nephropathy) and macrovascular (cerebral, 
myocardic, peripheral), all chronic complications of 
diabetes, are a major cause of premature death, 
reduced quality of life and disability.  
The World Health Organization defines diabetic foot 
as an infection, ulceration or the destruction of deep 
tissues of the foot associated with nephropathy and/or 
peripheral arterial disease.3 
The 2008 Consensus document of the international 
working group on the diabetic foot reports the 
following statements.4 
• Foot problems are common, very expensive, and 
life threatening. 
 Every 30 seconds a lower limb is lost somewhere 
in the world as a consequence of diabetes. 
 Up to 70% of all leg amputations are performed 
on people with diabetes. 
 Up to 85% of all amputations are preceded by an 
ulcer. 
 In developed countries, up to 5% of people with 
diabetes have a diabetic foot ulcer  
 12% to 15% of health care resources are used for 
diabetes. 
 
More attention is being paid to the quality of life of 
patients with diabetic foot ulcers and amputees whose 
quality of life is diminished at the same rate as that for 
patients with cancer or those with chronic kidney 
disease undergoing dialysis 17. No doubt the lives of 
people after amputation are profoundly affected. 
Many are unable to work, become dependent on 
others and cannot pursue an active social life. In 
developing countries, the situation is even worse 
because a whole family may have no income if the 
active member is suffering from a chronic ulcer or has 
undergone amputation. 
 
II.  PHYSIOPATHOLOGY 
 
The Physiopathology of the diabetic foot is rather 
complex. If diabetes is not controlled for several 
years, complications frequently arise. Vasculopathy 
and neuropathy are the most important complications 
leading to diabetic foot problems. Small traumas can 
have devastating effects. As primary care physicians 
treating diabetes, we need to consider three important 
factors: vasculopathy/neuropathy/trauma will lead to 
an ulcer. Infection increases the chances of 
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amputation, especially if the patient has poor 
peripheral circulation. 
Diabetic peripheral neuropathy is characterized by the 
involvement of all fibers (sensory, motor and 
autonomic). Motor neuropathy results in atrophy and 
weakness of the muscles of the foot, leg and joint 
rigidity with consequent abnormal walking patterns 
resulting in an increase of peek pressure on the plantar 
aspect of the foot. 
As a consequence of muscle impairment and joint 
rigidity foot deformities may cause ulcers on both the 
plantar and dorsal sides of the foot. Autonomic 
neuropathy results in reduced or absent sweating 
leading to dry skin with cracks and fissures. 
 
III. RISK FACTOR MODIFICATION 
 
Cardiovascular morbidity and mortality are markedly 
increased in patients with peripheral artery disease. 
Therefore, treatment of neuroischemic ulcers should 
not be solely focused on the foot but should also aim 
to reduce poor survival rates. In patients without 
diabetes, cessation of smoking has been shown to 
decrease the risk of developing intermittent 
claudication and decrease the subsequent risk of 
amputation. Moreover, if the patient stops smoking, 
patency rates for vascular reconstruction are higher 
and the risk of death is lower. 
Although there are no studies that can demonstrate 
that treating hypertension and dyslipidemia have any 
beneficial effects. 
The involvement of sympathetic nerve fibers causes 
increased arteriovenous shunting which leads to a 
overheated and edematous foot with distended dorsal 
foot veins. 
Sensory neuropathy may reduce pain perception, 
increasing the risk of ulceration secondary to 
repetitive trauma during walking8-10. Insensitive 
callus on the plantar foot surface caused by peak of 
pressure frequently anticipates the onset of a 
neuropathic plantar ulcers 5,6,11. 
Charcot neuro-osteoarthropathy is a devastating 
complication of diabetic foot syndrome. Acute 
Charcot usually presents with a hot, inflamed, swollen 
and sometimes painful foot without skin lesions - 
clear differentiation from infection is mandatory to 
ensure appropriate management. Progression is often 
rapid with bone fragmentation and joint destruction 
followed by a longitudinal arch of the foot is a 
common evolution leading to typical “rocker bottom” 
deformity with a high risk of deep infection ulcers.11 
 
IV. SURGICAL TREATMENT 
 
Surgical treatment of infected superficial ulcers of 
the foot. 
Debridement of an infection of the superficial ulcer 
consists of removal of a necrotic or non-vital tissue 
with exposure of a healthy and bleeding wound bed. 
Once the infected and/or necrotic tissue has been 
removed, negative pressure wound therapy is 
generally used to guarantee the cleansing of the 
wound bed and the quick removal of all exudates 
which could still be contaminated by residual deep 
bacterial colonies.  
 
Surgical treatment of deep infection of the foot 
The infectious process of a diabetic foot can start 
directly with the involvement of the deep structure of 
the foot but very often represents a late complication 
of a superficial ulcer or wet gangrene not correctly 
treated. From a clinical point of view, infection of the 
foot can be classified as follows: 
1. Phlegmon 
2. Infective compartment syndrome 
3. Necrotizing fasciitis 
 
Gangrene – Gangrene represents the final evolution 
in insufficient blood perfusion of the tissue. While dry 
gangrene doesn’t represent an emergent clinical status 
due lack of infection, wet gangrene, which is often the 
final evolution of an infected superficial ulcer in the 
presence of CLI, needs to be treated immediately to 
avoid further worsening of the infection. 
 
V. REVASCULARIZATION PROCEDURE 
 
Revascularization is a key therapy in ischemic 
diabetic lesions because re-establishing an adequate 
blood supply to the wound is essential for avoiding 
major amputation12.  
1. Our first approach is an “angioplasty first” strategy 
however in the face of extremely long femoro-
popliteal and/or below the knee vessel obstruction, the 
correct decision is not simple.13 In these cases the 
patient’s  clinical status, foot lesion,  suitability of 
veins and of a correct landing zone for distal bypass 
must be considered. Percutaneous revascularization 
doesn’t need general anesthesia and can be easily 
carried out in high surgical risk patients due to 
age/comorbidities and reduced life expectancy. 
Percutaneous revascularization can be divided into 
multiple steps and be repeated in case of restenosis. It 
can be performed in foot lesions involving distal 
anastomosis sites, in case of absence of adequate 
veins or if distal bypass surgery guarantees superior 
long-term patency. 
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2. Targets of revascularization therapy: complete 
revascularization is better than partial 
revascularization.14-15 The first principle guiding our 
revascularization strategy must be to give to the foot 
the best possible blood supply. Another emerging 
concept is the “wound related artery” 
revascularization.16 Following the angiosome 
concept, a successful angioplasty or bypass of the 
artery directly feeding the wound region leads to 
higher rates of limb salvage and wound healing. 
3. We try to perform the angiographic study and the 
percutaneous revascularization in the same session. 
The procedure must be tailored to technically realistic 
strategies and on general patient status. 
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